Skip to Content

WPI 839 (Bupropion Hydrochloride Extended-Release (SR) 150 mg)

Pill with imprint WPI 839 is White, Round and has been identified as Bupropion Hydrochloride Extended-Release (SR) 150 mg. It is supplied by Watson Pharmaceuticals.

Bupropion is used in the treatment of major depressive disorder; depression; smoking cessation; seasonal affective disorder and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 839

Bupropion hydrochloride extended-release (SR) 150 mg WPI 839
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839  Front
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839  Back

Bupropion Hydrochloride Extended-Release (SR)

Imprint
WPI 839
Strength
150 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Miscellaneous antidepressants, Smoking cessation agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-0839

Get help with Imprint Code FAQs.

Related Images for "WPI 839"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.